Assuming risk is required, the following results were found.

  • Fooling nerve cells into acting normal

    Discovery could inform future studies related to spinal cord injuries, multiple sclerosis and epilepsy Date:Source:University of Missouri-ColumbiaSummary:Scientists have discovered that a neuron's own electrical signal, or voltage, can indicate whether...

    https://mschristian.org/index.php/blog/fooling-nerve-cells-into-acting-normal
  • Can Anti-TNF Drugs Reduce Alzheimer's Risk?

    Systemic inflammatory diseases involving tumor necrosis factor (TNF) increased the risk of Alzheimer's disease, but that risk was reduced in patients who used anti-TNF biologics, an analysis of 56 million adults' electronic health records showed. While...

    https://mschristian.org/index.php/articles/2-uncategorised/8833-can-anti-tnf-drugs-reduce-alzheimer-s-risk
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    and News Continuing Tysabri (natalizumab) treatment up to week 28 of pregnancy, and restarting soon after birth, reduces the risk of relapses in women with multiple sclerosis and appears to be safe for the mother and the baby, new research suggests....

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • Can Anti-TNF Drugs Reduce Alzheimer's Risk?

    Systemic inflammatory diseases involving tumor necrosis factor (TNF) increased the risk of Alzheimer's disease, but that risk was reduced in patients who used anti-TNF biologics, an analysis of 56 million adults' electronic health records showed. While...

    https://mschristian.org/index.php/blog/can-anti-tnf-drugs-reduce-alzheimer-s-risk
  • MS Risk Nearly Doubles 15 Years Following Teen Concussion - Medscape

    STOCKHOLM — People who experience a concussion during adolescence are at significantly elevated risk for multiple sclerosis (MS) later in life, especially 15 years or more following their head trauma, a large retrospective study suggests. This risk for...

    https://mschristian.org/index.php/articles/2-uncategorised/8693-ms-risk-nearly-doubles-15-years-following-teen-concussion-medscape
  • From The CDC - Center for Disease Control : Coronavirus Disease 2019 (COVID-19)

    Who is at higher risk? Early information out of China, where COVID-19 first started, shows that some people are at higher risk of getting very sick from this illness. This includes: Older adultsPeople who have serious chronic medical conditions...

    https://mschristian.org/index.php/blog/from-the-cdc-center-for-disease-control-coronavirus-disease-2019-covid-19
  • MS Risk Nearly Doubles 15 Years Following Teen Concussion - Medscape

    STOCKHOLM — People who experience a concussion during adolescence are at significantly elevated risk for multiple sclerosis (MS) later in life, especially 15 years or more following their head trauma, a large retrospective study suggests. This risk for...

    https://mschristian.org/index.php/blog/ms-risk-nearly-doubles-15-years-following-teen-concussion-medscape
  • Demyelinating Risks With Anti-TNF Vary in Rheumatic Diseases - MedPage Today

    Patients with certain types of arthritic conditions were at elevated risk for developing neuroinflammatory events if treated with tumor necrosis factor (TNF) inhibitors, a large prospective cohort study conducted in Denmark and Sweden found. Among...

    https://mschristian.org/index.php/blog/demyelinating-risks-with-anti-tnf-vary-in-rheumatic-diseases-medpage-today
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    and News Continuing Tysabri (natalizumab) treatment up to week 28 of pregnancy, and restarting soon after birth, reduces the risk of relapses in women with multiple sclerosis and appears to be safe for the mother and the baby, new research suggests....

    https://mschristian.org/index.php/articles/2-uncategorised/8640-ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • New 6-Year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in Relapsing Multiple Sclerosis

    Post-hoc analysis from 6 years of Phase III open-label extension studies showed Ocrevus treatment reduced the risk of needing a walking aid (EDSS≥6) by 49% in relapsing multiple sclerosis (RMS) patients compared with patients who switched from...

    https://mschristian.org/index.php/blog/new-6-year-data-for-genentech-s-ocrevus-ocrelizumab-show-earlier-treatment-initiation-nearly-halves-risk-of-needing-walking-aid-in-relapsing-multiple-sclerosis
  • Mechanism controlling multiple sclerosis risk identified

    predisposed individuals. Researchers at Karolinska Institutet in Sweden have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective...

    https://mschristian.org/index.php/blog/mechanism-controlling-multiple-sclerosis-risk-identified
  • Who’s Willing to Accept More DMT Risk, You or Your Neuro?

    disease-modifying therapies (DMTs) are being made available, people with multiple sclerosis have to decide how much risk they’re willing to accept in exchange for the treatment’s potential benefits. It’s a tough decision not made any easier if a...

    https://mschristian.org/index.php/articles/2-uncategorised/9625-who-s-willing-to-accept-more-dmt-risk-you-or-your-neuro
  • Smoking may increase risk of stroke - Taipei Times

    A doctor warned that smokers could increase their risk of having a stroke by 12 percent and they run a 1.81 times greater risk of developing multiple sclerosis. Health Promotion Administration (HPA) data show that as many as 35.6 percent of recovering...

    https://mschristian.org/index.php/articles/2-uncategorised/9684-smoking-may-increase-risk-of-stroke-taipei-times
  • Tecfidera (dimethyl fumarate)

    relapsing forms of multiple sclerosis (MS). Tecfidera is classified as a disease-modifying therapy for MS. It reduces the risk of MS relapse by up to 49 percent over two years. It also reduces the risk of having worsening physical disability by about 38...

    https://mschristian.org/index.php/blog/tecfidera-dimethyl-fumarate
  • Mechanism controlling multiple sclerosis risk identified

    predisposed individuals. Researchers at Karolinska Institutet in Sweden have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective...

    https://mschristian.org/index.php/articles/2-uncategorised/4201-mechanism-controlling-multiple-sclerosis-risk-identified
  • Weekend Warriors Be Warned: Irregular Sleep Patterns Linked to CV Risk

    The more variable a person's sleep schedule, the greater his or her risk of cardiovascular disease (CVD), data from the Multi-Ethnic Study of Atherosclerosis (MESA) showed. A larger range in individual sleep duration and sleep timing across 7 days of...

    https://mschristian.org/index.php/blog/weekend-warriors-be-warned-irregular-sleep-patterns-linked-to-cv-risk
  • MS: Common herpesvirus variant raises risk

    distinguishes between two similar variants of the human herpesvirus 6 and finds that one variant significantly increases the risk of developing multiple sclerosis (MS). Share on Pinterest Scientists have linked the Epstein-Barr virus (depicted here)...

    https://mschristian.org/index.php/articles/2-uncategorised/9447-ms-common-herpesvirus-variant-raises-risk
  • Tecfidera (dimethyl fumarate)

    relapsing forms of multiple sclerosis (MS). Tecfidera is classified as a disease-modifying therapy for MS. It reduces the risk of MS relapse by up to 49 percent over two years. It also reduces the risk of having worsening physical disability by about 38...

    https://mschristian.org/index.php/articles/2-uncategorised/8434-tecfidera-dimethyl-fumarate
  • Living near major roads linked to risk of dementia, Parkinson's, Alzheimer's and MS

    found that living less than 50 metres from a major road or less than 150 metres from a highway is associated with a higher risk of developing dementia, Parkinson's, Alzheimer's and MS -- likely due to increased exposure to air pollution. The researchers...

    https://mschristian.org/index.php/articles/2-uncategorised/9836-living-near-major-roads-linked-to-risk-of-dementia-parkinson-s-alzheimer-s-and-ms
  • Living near major roads linked to risk of dementia, Parkinson's, Alzheimer's and MS - YubaNet

    found that living less than 50 metres from a major road or less than 150 metres from a highway is associated with a higher risk of developing dementia, Parkinson’s, Alzheimer’s and MS—likely due to increased exposure to air pollution. Advertisement The...

    https://mschristian.org/index.php/articles/2-uncategorised/9849-living-near-major-roads-linked-to-risk-of-dementia-parkinson-s-alzheimer-s-and-ms-yubanet

Results 1 - 20 of 320